The timeliness of health plan drug coverage policy changes to FDA label revisions
Despite many policies already aligning with FDA label revisions, coverage updates were often slow and inconsistent. Improving timeliness may improve equitable access to care.
Authors
- Jonathan D. Campbell (ORCID: https://orcid.org/0000-0001-6539-1258)
- JD Chambers
- James Motyka (ORCID: https://orcid.org/0009-0006-9216-0141)
- Molly T. Beinfeld
- Claire H Brennan
- Angela Lin
- Daniel E Enright
Institutions
- Tufts Medical Center (US)
- National Health Council (US)
Publication Details
- Journal
- Health Affairs Scholar
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1093/haschl/qxag034
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00